StrokeAlert

We are a small Israeli startup company developing a medical device for alerting stroke in sleep/ sedation. We currently have 3 R&D employees.

StrokeAlert was founded to develop, manufacture, and introduce the first easy-to-use device for

alerting stroke for high-risk populations. The first market is hospital use during sedation, with the end-stage

the market being home telemonitoring. The company has a clear patentable product, a large growing market, and

an expert and experienced team. StrokeAlert’s intellectual property is an alerting system via continuous

monitoring of hemodynamic parameters (patent pending).

First Target Market- perioperative stroke is for operating rooms (OR) and intensive-care units (ICU).

The estimated high-risk populations for stroke are 1M in OR and 2M in ICUs with 3M users per year in the US. The

unit price is 100$ for a pair of single-use sensors (with 20% -50% wear for OR and ICU respectively); and a

$10k price for the device (7200 US hospitals, five devices per hospital). The total addressable market (TAM)

for the sensors alone is estimated at 780M$ annually. Currently, available devices are not useful for stroke

monitoring.

To conduct clinical trials of the medical device developed by StrokeAlert. Details of its features are as follows:

StrokeAlert will detect unilateral carotid flow changes reflecting stroke to provide timely alerts enabling early intervention. The expected outcome: StrokeAlert expects to decrease morbidity and mortality from perioperative stroke by a third (large vessel occlusion). StrokeAlert lowers the devastating impact on a

person’s quality of life-extending beyond the individual boundaries to various stakeholders.

StrokeAlert’s unique value proposition is by providing continuous monitoring enablingautomated alerts during sleep/ sedation. Given the narrow therapeutic window of treatment options, candidacy is dependent on timely recognition. The product comprises a device, wireless, single-use sensors adhered to the

skin overlying a major artery and an underlying algorithm, producing an alert to a possible stroke, relying on data accumulated from hemodynamic changes during stroke occurrence.

Develop the medical device

We are seeking a partner for clinical studies: a CRO or large medical center with active intracranial use of ballons (at least once a week).